Sphere 3D Awarded Contract Valued at Approximately $3 Million
Mar 30, 2017 12:33 pm UTC| Business
SAN JOSE, Calif., March 30, 2017 -- Sphere 3D Corp. (NASDAQ:ANY), a containerization, virtualization and data management solutions provider, is pleased to announce that it has been awarded a contract valued at...
Mar 30, 2017 12:32 pm UTC| Business
BRIDGEWATER, N.J., March 30, 2017 -- Valeritas Holdings, Inc. (NASDAQ:VLRX) today announced the publication of an article that highlights the benefit of diabetes medication delivery devices, including Valeritas’ V-Go®...
Mar 30, 2017 12:32 pm UTC| Business
BRIDGEWATER, N.J., March 30, 2017 -- Valeritas Holdings, Inc. (NASDAQ:VLRX) today announced the publication of an article that highlights the benefit of diabetes medication delivery devices, including Valeritas’ V-Go®...
Mar 30, 2017 12:32 pm UTC| Business
BRIDGEWATER, N.J., March 30, 2017 -- Valeritas Holdings, Inc. (NASDAQ:VLRX) today announced the publication of an article that highlights the benefit of diabetes medication delivery devices, including Valeritas’ V-Go®...
Mar 30, 2017 12:32 pm UTC| Business
MADISON, Wis., March 30, 2017 -- Madison, Wis. Cellectar Biosciences, Inc. (Nasdaq:CLRB), an oncology-focused clinical stage biotechnology company, today announces the initiation of a Phase II clinical study of its lead...
Mar 30, 2017 12:32 pm UTC| Business
MADISON, Wis., March 30, 2017 -- Madison, Wis. Cellectar Biosciences, Inc. (Nasdaq:CLRB), an oncology-focused clinical stage biotechnology company, today announces the initiation of a Phase II clinical study of its lead...
Mar 30, 2017 12:32 pm UTC| Business
MADISON, Wis., March 30, 2017 -- Madison, Wis. Cellectar Biosciences, Inc. (Nasdaq:CLRB), an oncology-focused clinical stage biotechnology company, today announces the initiation of a Phase II clinical study of its lead...